Beatriz Morancho

1.7k total citations
19 papers, 648 citations indexed

About

Beatriz Morancho is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Beatriz Morancho has authored 19 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Molecular Biology. Recurrent topics in Beatriz Morancho's work include Monoclonal and Polyclonal Antibodies Research (7 papers), HER2/EGFR in Cancer Research (6 papers) and Aldose Reductase and Taurine (3 papers). Beatriz Morancho is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), HER2/EGFR in Cancer Research (6 papers) and Aldose Reductase and Taurine (3 papers). Beatriz Morancho collaborates with scholars based in Spain, United States and Palestinian Territory. Beatriz Morancho's co-authors include J. Aramburu, Jordi Minguillón, Cristina López-Rodrı́guez, Joaquı́n Arribas, Katherine Drews‐Elger, Teresa Auguet, Cristóbal Richart, Montserrat Broch, Carmen Aguilar and Marta Escorihuela and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Beatriz Morancho

19 papers receiving 635 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beatriz Morancho Spain 13 224 192 146 142 104 19 648
Lisa S. Ang Canada 11 276 1.2× 116 0.6× 75 0.5× 44 0.3× 82 0.8× 14 725
Nhat‐Tu Le United States 16 480 2.1× 135 0.7× 71 0.5× 62 0.4× 85 0.8× 22 838
Pavel Pitule Czechia 16 429 1.9× 264 1.4× 157 1.1× 133 0.9× 38 0.4× 29 884
Edwige Tellier France 13 401 1.8× 79 0.4× 123 0.8× 60 0.4× 122 1.2× 25 786
Vidar Staalesen Norway 11 299 1.3× 159 0.8× 189 1.3× 129 0.9× 59 0.6× 12 654
Barbara Salani Italy 16 547 2.4× 116 0.6× 143 1.0× 55 0.4× 190 1.8× 27 873
Lina Wu China 15 202 0.9× 86 0.4× 48 0.3× 101 0.7× 52 0.5× 61 753
Yasuhisa Oida Japan 20 432 1.9× 396 2.1× 61 0.4× 176 1.2× 205 2.0× 58 1.1k
Yukio Tokumitsu Japan 13 233 1.0× 215 1.1× 77 0.5× 76 0.5× 40 0.4× 62 740
Suvi E. Heinonen Finland 12 221 1.0× 99 0.5× 78 0.5× 59 0.4× 28 0.3× 24 559

Countries citing papers authored by Beatriz Morancho

Since Specialization
Citations

This map shows the geographic impact of Beatriz Morancho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beatriz Morancho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beatriz Morancho more than expected).

Fields of papers citing papers by Beatriz Morancho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beatriz Morancho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beatriz Morancho. The network helps show where Beatriz Morancho may publish in the future.

Co-authorship network of co-authors of Beatriz Morancho

This figure shows the co-authorship network connecting the top 25 collaborators of Beatriz Morancho. A scholar is included among the top collaborators of Beatriz Morancho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beatriz Morancho. Beatriz Morancho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Morancho, Beatriz, Marta Escorihuela, Irene Chicote, et al.. (2022). The target antigen determines the mechanism of acquired resistance to T cell-based therapies. Cell Reports. 41(3). 111430–111430. 8 indexed citations
2.
Casadevall, David, Sara García‐Alonso, Sílvia Menéndez, et al.. (2022). mTOR Inhibition and T-DM1 in HER2-Positive Breast Cancer. Molecular Cancer Research. 20(7). 1108–1121. 15 indexed citations
3.
Nadal‐Serrano, Mercedes, Marta Lalinde-Gutiérrez, Enrique J. Arenas, et al.. (2022). Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody–Drug Conjugates in Breast Cancer. Cancer Research. 82(24). 4670–4679. 31 indexed citations
4.
Nadal‐Serrano, Mercedes, Beatriz Morancho, Santiago Escrivá-de-Romaní, et al.. (2020). The Second Generation Antibody-Drug Conjugate SYD985 Overcomes Resistances to T-DM1. Cancers. 12(3). 670–670. 39 indexed citations
5.
Gorbatenko, Andrej, Rolf Søkilde, Helena Persson, et al.. (2019). HER2 and p95HER2 differentially regulate miRNA expression in MCF-7 breast cancer cells and downregulate MYB proteins through miR-221/222 and miR-503. Scientific Reports. 9(1). 3352–3352. 20 indexed citations
6.
7.
Morancho, Beatriz, Mariano F. Zacarías Fluck, Antonio Esgueva, et al.. (2016). Modeling anti-IL-6 therapy using breast cancer patient-derived xenografts. Oncotarget. 7(42). 67956–67965. 5 indexed citations
8.
Vicario, Rocío, Vicente Peg, Beatriz Morancho, et al.. (2015). Patterns of HER2 Gene Amplification and Response to Anti-HER2 Therapies. PLoS ONE. 10(6). e0129876–e0129876. 41 indexed citations
9.
Morancho, Beatriz, Águeda Martínez‐Barriocanal, Josep Villanueva, & Joaquı́n Arribas. (2015). Role of ADAM17 in the non-cell autonomous effects of oncogene-induced senescence. Breast Cancer Research. 17(1). 106–106. 11 indexed citations
10.
Fluck, Mariano F. Zacarías, Beatriz Morancho, Rocío Vicario, et al.. (2015). Effect of Cellular Senescence on the Growth of HER2-Positive Breast Cancers. JNCI Journal of the National Cancer Institute. 107(5). djv020–djv020. 36 indexed citations
11.
García-Parra, Jetzabel, Alba Dalmases, Beatriz Morancho, et al.. (2014). Poly (ADP-ribose) polymerase inhibition enhances trastuzumab antitumour activity in HER2 overexpressing breast cancer. European Journal of Cancer. 50(15). 2725–2734. 22 indexed citations
12.
Parra-Palau, Josep Lluís, Beatriz Morancho, Vicente Peg, et al.. (2014). Effect of p95HER2/611CTF on the Response to Trastuzumab and Chemotherapy. JNCI Journal of the National Cancer Institute. 106(11). 42 indexed citations
13.
Morancho, Beatriz, Katherine Drews‐Elger, Benoı̂t Viollet, et al.. (2012). Transcriptional regulation of gene expression during osmotic stress responses by the mammalian target of rapamycin. Nucleic Acids Research. 40(10). 4368–4384. 41 indexed citations
14.
Morancho, Beatriz, Josep Lluís Parra-Palau, Yasir H. Ibrahim, et al.. (2012). A dominant-negative N-terminal fragment of HER2 frequently expressed in breast cancers. Oncogene. 32(11). 1452–1459. 7 indexed citations
15.
Auguet, Teresa, Yunuen Quintero, David Riesco, et al.. (2011). New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Medical Genetics. 12(1). 60–60. 156 indexed citations
16.
Auguet, Teresa, Francesc Vidal, Montserrat Broch, et al.. (2010). Polymorphisms in the interleukin-10 gene promoter and the risk of alcoholism and alcoholic liver disease in Caucasian Spaniard men. Alcohol. 44(3). 211–216. 7 indexed citations
17.
Morancho, Beatriz, Jordi Minguillón, Jeffery D. Molkentin, Cristina López-Rodrı́guez, & J. Aramburu. (2008). Analysis of the transcriptional activity of endogenous NFAT5 in primary cells using transgenic NFAT-luciferase reporter mice. BMC Molecular Biology. 9(1). 13–13. 35 indexed citations
18.
Aramburu, J., et al.. (2006). Regulation of the hypertonic stress response and other cellular functions by the Rel-like transcription factor NFAT5. Biochemical Pharmacology. 72(11). 1597–1604. 99 indexed citations
19.
Minguillón, Jordi, Beatriz Morancho, Seong‐Jin Kim, Miguel López‐Botet, & J. Aramburu. (2005). Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-β1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-β1. Journal of Leukocyte Biology. 77(5). 748–758. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisa S. Ang Breakdown of academic impact, for papers by Nhat‐Tu Le Breakdown of academic impact, for papers by Pavel Pitule Breakdown of academic impact, for papers by Edwige Tellier Breakdown of academic impact, for papers by Vidar Staalesen Breakdown of academic impact, for papers by Barbara Salani Breakdown of academic impact, for papers by Lina Wu Breakdown of academic impact, for papers by Yasuhisa Oida Breakdown of academic impact, for papers by Yukio Tokumitsu Breakdown of academic impact, for papers by Suvi E. Heinonen
Rankless by CCL
2026